PubMed Health⌕ Search

Biomedical subjects

J T Bowers

Publications and source records attributed to J T Bowers.

4 recordsLinked to original sources

Thermoelastic properties of uniaxially deformed lung strips.

We examined the temperature dependence of small degassed hamster lung strip mechanics to develop insights into the molecular basis of lung elasticity. Quasi-static length-tension curves of adapted lung strips were generated at 10, 23, 37, 50, and 80 degrees C; quasi-static tension-temperature plots (QSTT) at strains of 0.5, 0.75, and 1.0 were then formulated. Static tension-temperature (STT) plots at strain 1 were independently generated from other strips. Stress relaxation was evaluated as a function of temperature at different strains; hysteresis ratio was calculated as a parameter of mechanical efficiency. Between 23 and 37 degrees C, the slopes of the QSTT plots at the different strains were close to zero. The slope of the STT plot was slightly positive, indicating that the tension developed by a stretched strip was primarily due to entropic changes with length, suggesting that strips behave like rubber polymers near physiological temperature. Between 10 and 23 degrees C, the slope of the QSTT curve was zero at the two lowest strains but was negative at strain 1; and slope of the STT curve was zero at strain 1. These data indicated that collagen fiber and possibly glycosaminoglycan function was abnormally affected at 10 degrees C. Between 50 and 80 degrees C at strain 1, the slopes of both the QSTT and STT plots at all strains were positive. These data suggested that elastic fiber function was altered between 50 and 80 degrees C such that both internal energetic and entropic contributions to the tension were changed. Stress relaxation and hysteresis data were consistent with these findings.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Posthyperventilation apnea associated with severe hypoxemia.

We studied a 14-year-old girl who suffered fractures of her mandible and tegmen following a fall from a balance beam. Thirteen days after hospitalization, she developed severe, protracted, recurrent episodes of hyperventilation; subsequently, she suffered posthyperventilation apnea, which at times was prolonged and association with severe hypoxemia with an arterial oxygen pressure as low as 25 mm Hg. The patient was treated with added dead space and chlorpromazine hydrochloride (Thorazine). Postulated mechanisms for her disorder are discussed. The importance of close clinical and laboratory observation in similar cases is stressed.

Adolescent↗

Moxalactam therapy vs. standard antimicrobial therapy for selected serious infections.

Moxalactam was studied in a prospective randomized clinical trial in 97 hospitalized patients suspected of having infection caused by moxalactam-susceptible bacteria. Seventy-eight of the 97 patients had clinical and/or bacteriologic evidence of infection, including pneumonia, cellulitis, urinary tract infection, bacteremia, and fever in neutropenic patients. Patients in the control group received antibiotics deemed appropriate by the attending physicians, whereas the moxalactam-treated group received only the study drug. Successful treatment was defined as the resolution of illness sufficient to allow discontinuation of parenteral antibiotic therapy. No significant difference was seen in efficacy with 33 (86.8%) of 38 patients in the moxalactam-treated group and 32 (80%) of 40 in the control group treated successfully (P greater than 0.20). The mean number of febrile days was significantly less in the moxalactam-treated group than in the control group (P less than 0.05). Renal toxicity occurred more frequently in the control group (P = 0.036). Fungal superinfection developed in two patients in the control group and in one in the moxalactam-treated group. An enterococcal superinfection of the bloodstream developed in one patient treated with moxalactam. Thus moxalactam appears to be comparable in efficacy to combinations of antibiotics in the treatment of selected seriously ill patients and may have less renal toxicity.

Anti-Bacterial Agents↗